Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
Clinical trial NCT03653052 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03653052
- Sponsor
- Simon C Pacey, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2021-11-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.